2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
4
Breast Neoplasms
3
Recurrence
2
Paraproteinemias
2
Papillomavirus Infections
2
Immunoglobulin Light-chain Amyloidosis
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Complications
1
Pneumonia
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Obesity
1
Neoplasms, Plasma Cell
1
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Locally Advanced Breast Cancer
1
Intermittent Fasting
1
Hypothyroidism
1
Interventions
Cisplatin
281
pembrolizumab
234
Radiotherapy
171
Cetuximab
169
Carboplatin
123
Docetaxel
110
Paclitaxel
96
Fluorouracil
95
Nivolumab
88
Radiotherapy, Intensity-Modulated
80
Magnetic Resonance Spectroscopy
39
durvalumab
36
Radiation
33
Surgical Procedures, Operative
32
Drug Therapy
32
Biopsy
28
Radiosurgery
25
Erlotinib Hydrochloride
25
Albumin-Bound Paclitaxel
24
130-nm albumin-bound paclitaxel
24
Taxes
23
Specimen Handling
22
Platinum
22
Immunohistochemistry
21
tislelizumab
20
1,2-diaminocyclohexaneplatinum II citrate
20
Cyclophosphamide
19
Chemoradiotherapy
19
Capecitabine
19
tremelimumab
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Clinical Protocols
×
Clear all
NCT06130007
2023-11-13
B2023-153
Sun Yat-sen University
Phase 2
Unknown
48 enrolled